US Pharma MarketingArgenx signs agreement to buy Forte Biosciences for $2.2bn
Argenx signs agreement to buy Forte Biosciences for $2.2bn is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
argenx has entered into a definitive agreement to acquire Forte Biosciences for approximately $2.2bn in total equity value.
Source: Pharmaceutical Technology